Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 31Burkitt Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Mantle-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Biphenotypic, Acute 3Immunoglobulin Light-chain Amyloidosis 3Smoldering Multiple Myeloma 2Recurrence 2Neoplasms, Plasma Cell 2Neoplasms 2Lung Neoplasms 2Leukemia, Plasma Cell 2Brain Neoplasms 2Blast Crisis 2Renal Insufficiency 1Prostatic Neoplasms 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Neoplasm Metastasis 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Hodgkin Disease 1

Interventions

Cyclophosphamide 33fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 19Mycophenolic Acid 17Whole-Body Irradiation 15Etoposide 15Rituximab 14Tacrolimus 13Busulfan 12Vincristine 11Prednisone 11Methotrexate 11Filgrastim 11Doxorubicin 11Cyclosporine 11Radiotherapy 10Brentuximab Vedotin 10Antilymphocyte Serum 10Methylprednisolone 8Cytarabine 8Melphalan 7Cisplatin 6Ifosfamide 5Gemcitabine 5merphos 4ibritumomab tiuxetan 4Sirolimus 4Flow Cytometry 4Dexamethasone 4Cyclosporins 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large-Cell, Anaplastic × dexamethasone acetate × Clear all
NCT01979536 2024-04-30

Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

National Cancer Institute (NCI)

Phase 2 Completed
137 enrolled 13 charts
Lymphoid

Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡